paclitaxel
推荐文章
释义
特素；
权威例句
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III o...
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously ...
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Arte...
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from ...
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-l...
1. Paclitaxel adheres to the balloon until it is expanded.
直到球囊展开，紫杉醇一直粘附在其上面。
youdao
2. Another 54 people did not receive paclitaxel in any form.
另外54人未接受任何形式的紫杉醇。
youdao
3. Paclitaxel is considered one of the most promising antitumor druggery.
紫杉醇是当今最有效的抗癌药物之一。
youdao
4. Objective To evaluate the effect of paclitaxel combined DDP on advanced breast cancer.
目的评价紫杉醇联合顺铂对晚期乳腺癌的治疗作用。
youdao
5. Objective To investigate the efficacy and safety of slow release paclitaxel eluting stents.
目的评价紫杉醇慢速释放支架的近期安全性及效果。
youdao
6. Clinical non cross resistance had been demonstrated between TPT and cisplatin or paclitaxel.
临床试验表明，TPT与顺铂和紫杉醇无交叉耐药性。
youdao
7. The Clinical Pharmacology, adverse reactions, Clinical uses, and precautions of Paclitaxel were reviewed.
介绍了紫杉醇的临床药理、临床应用、不良反应和使用注意事项。
youdao
8. To investigate the proliferative effect of paclitaxel against humananaplastic thyroid carcinoma cells (DRO).
观察不同浓度的紫杉醇对人甲状腺未分化癌细胞DRO生长的影响。
youdao
9. Objective To study the ideal method of the renovation in the tissue damage by paclitaxel vascular extravasation.
目的为了探讨紫杉醇静脉注射外渗后局部组织损伤修复的理想方法。
youdao
10. To study the efficacy and tolerance of paclitaxel therapy for metastatic breast cancer with adriamycin resistance.
目的研究紫杉醇治疗阿霉素耐药的晚期乳腺癌的疗效和耐受性。
youdao
11. Conclusion: the combination of paclitaxel and cisplatin was an effective regimen as neoadjuvant chemotherapy for LAEC.
结论：紫杉醇联合顺铂新辅助化疗方案治疗中晚期食管癌疗效显著。
youdao
12. Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
目的探讨紫杉醇（PTX）为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
youdao
13. Objective: on the basis of the national standard, we have studied on bacterial endotoxins test for Paclitaxel Injection.
目的：在现行的国家标准的基础上对紫杉醇注射液细菌内毒素检查法进行再研究。
youdao
14. Objective: To inspect the effect of activated carbon with different dosage and temperature on quality of paclitaxel injection.
目的：考察活性炭用量和温度对紫杉醇注射液质量的影响。
youdao
15. OBJECTIVE To study the influence of interior gelatinization on the stability of freeze dried liposomes with paclitaxel loaded.
目的制备载紫杉醇内部胶凝化脂质体，考察内部胶凝在冷冻干燥中对脂质体的稳定作用。
youdao
16. Objective To investigate the radiosensitizing enhancement effect of paclitaxel on human adenoid cystic carcinoma ACC 2 line cell.
目的评价紫杉醇对人腺样囊性癌细胞株acc- 2的辐射增敏作用。
youdao
17. Objective: to study the effect and toxicities of China made paclitaxel in the treatment of advanced epithelial ovarian carcinoma.
目的：探讨国产紫杉醇治疗晚期卵巢上皮性癌的疗效及其毒性。
youdao
18. Objective to observe the efficacy and toxicities of paclitaxel combined with DDP in treatment of advanced nasopharyngeal carcinoma.
目的观察紫杉醇联合顺铂治疗远处转移的晚期鼻咽癌的疗效和毒副反应。
youdao
19. OBJECTIVE To study the preparation of paclitaxel entrapped magnetic non ionic surfactant vesicles (tax MNS) and evaluate its quality.
目的：对紫杉醇磁性非离子表面活性剂泡囊的处方和制备工艺进行研究，并评价其质量。
youdao
20. ObjectiveTo observe the effect of oral prednisone to relieve paclitaxel-induced arthralgia and myalgia in patients with ovarian cancer.
目的观察卵巢癌患者化疗时口服强的松对紫杉醇引起的关节痛和肌痛的缓解效果。
youdao
21. Results: Paclitaxel inhibited the growth of A375 cells by inducing apoptosis in a both time-dependent and dose-dependent manner(P
结果：紫杉醇通过诱导细胞凋亡抑制A375细胞生长，并呈时间和剂量依赖性（P
youdao
22. Cation - anion exchange resin can crack and disassemble bond - chromatography, doff the bond - large - molecule and dissociate paclitaxel.
阴阳混合离子交换树脂可以使键合态紫杉醇发生裂解，脱去键合的大分子物质，游离出紫杉醇。
youdao
23. Revascularization rates were similar with the sirolimus - and paclitaxel-eluting stents in the two trials, at 5.6% versus 5.3%, respectively.
再次血运重建率在西罗莫司和紫杉醇的两个临床试验类似，分别为5.6%和5.3%。
youdao
24. Objective to evaluate the relation of dose intensity and efficacy, toxicity in advanced breast cancer treated with paclitaxel as a single agent.
目的分析单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系。
youdao
25. The results showed that paclitaxel has inhibitory effect on angiogenesis strongly, it is a specific angiogenesis angiogenesis inhibiting factor.
结果表明，紫杉醇对血管生成有很强的抑制效应，证实紫杉醇是一种血管生成抑制因子。
youdao
26. Objective: to investigate the growth-inhibitory and apoptosis-inducing effect of paclitaxel on human melanoma A375 cell and its mechanism in vitro.
目的：探讨紫杉醇体外抑制人黑色素瘤细胞(A375细胞)增殖及诱导凋亡作用机制。
youdao
27. The median progression-free survival period with the drug combination was 11.8 months, twice as long as the 5.9 months achieved with paclitaxel alone.
药物联用的中值无进展存活期为11.8个月，是用单独紫杉醇获得的5.9个月的两倍。
youdao
28. Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again.
紫杉醇是一种常用于治疗乳腺癌和卵巢癌的化疗药物，但是，随着用药时间的延长，一些肿瘤可以对其产生抗药性，而又开始生长了。
youdao
29. Objective to evaluate the therapeutic effects and toxicities of paclitaxel and capecitabine combination regimen in the treatment of advanced breast cancer.
目的评价紫杉醇联合卡培他滨治疗晚期乳腺癌的疗效和毒副作用。
youdao
30. Objective to evaluate the therapeutic effects and toxicities of paclitaxel and capecitabine combination regimen in the treatment of advanced breast cancer.
目的评价紫杉醇联合卡培他滨治疗晚期乳腺癌的疗效和毒副作用。
youdao
31. The chemotherapy regimen was comprised of paclitaxel 60mg/m~2,iv gtt d1,8,15;
治疗方案为:特素60mg/m2iv gtt d1,8,15;
-- 来源 -- 网友提供
32. Objective To investigate the efficacy and safety of slow release paclitaxel eluting stents.
目的评价紫杉醇慢速释放支架的近期安全性及效果。
-- 来源 -- dict.cnki.net
paclitaxel
